Trinity Biotech receives non-compliance notice from Nasdaq
Trinity Biotech (TRIB) received notice from the Nasdaq Stock Market LLC that the company is not in compliance with Nasdaq Listing Rule ...
Trinity Biotech engages Barclays to advise on strategic realignment process
Trinity Biotech (TRIB) announces the next stage in realizing its comprehensive transformation plan and development of its continuous glucose ...
来自MSN1 个月
Trinity Biotech announces breakthrough in CGM technology
John Gillard, CEO of Trinity Biotech, emphasized that their patented technology is set to disrupt the CGM market, which is expected to surpass $20 billion by 2029. He highlighted the ergonomic ...